PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company Reports4D Pharma
4D Pharma(LBPS)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Annual sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Gilvetmab
lung neoplasms
,
small cell lung carcinoma
,
neoplasms
,
melanoma
,
urinary bladder neoplasms
,
esophageal squamous cell carcinoma
,
triple negative breast neoplasms
,
malignant mesothelioma
,
breast neoplasms
,
glioblastoma
,
colorectal neoplasms
,
pancreatic neoplasms
,
neoplasm metastasis
,
tumor virus infections
,
non-small-cell lung carcinoma
Microcrystalline cellulose
bronchitis
,
acute disease
,
urolithiasis
Globulin, immune
neoplasms
,
uveal neoplasms
,
uveal melanoma
,
melanoma
Mk3475
squamous cell carcinoma of head and neck
,
melanoma
,
recurrence
,
triple negative breast neoplasms
,
renal cell carcinoma
,
neoplasms
,
non-hodgkin lymphoma
,
multiple myeloma
,
urologic neoplasms
,
urinary bladder neoplasms
,
transitional cell carcinoma
,
colorectal neoplasms
,
prostatic neoplasms
,
non-small-cell lung carcinoma
,
carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
,
lung neoplasms
MRX0518
pancreatic neoplasms
,
prostatic neoplasms
,
breast neoplasms
,
ovarian neoplasms
,
head and neck neoplasms
,
lung neoplasms
,
uterine neoplasms
,
kidney neoplasms
,
urethral neoplasms
,
urinary bladder neoplasms
,
melanoma
,
renal cell carcinoma
,
neoplasms
,
non-small-cell lung carcinoma
,
oncogenes
,
urologic neoplasms
,
carcinoma
,
transitional cell carcinoma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use